CD4 and breast carcinoma: The presence of TILs, particularly CD8+ cytotoxic T cells and certain subsets of CD4+ T helper cells, within the TME is widely recognized as a favorable prognostic marker across multiple solid tumors, including melanoma, non-small cell lung cancer, bladder cancer, breast cancer, and ovarian cancer (118).